Next Article in Journal
Genetic Determinants of Non-Syndromic Enlarged Vestibular Aqueduct: A Review
Next Article in Special Issue
The Enduring Controversy of Cervicogenic Vertigo, and Its Place among Positional Vertigo Syndromes
Previous Article in Journal
Clinical Trial for Cartilage Conduction Hearing Aid in Indonesia
Previous Article in Special Issue
Benign Positional Paroxysmal Vertigo in Children
Brief Report

Benign Paroxysmal Positional Vertigo (BPPV) in COVID-19

Otolaryngology Institute-Department of Head and Neck, Fondazione Policlinico Universitario A Gemelli IRCCS, 00168 Rome, Italy
Otolaryngology Institute, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
Author to whom correspondence should be addressed.
Academic Editor: Jose A. Lopez-Escamez
Audiol. Res. 2021, 11(3), 418-422;
Received: 17 June 2021 / Revised: 12 July 2021 / Accepted: 4 August 2021 / Published: 13 August 2021
(This article belongs to the Special Issue Advances in Positional Vertigo)
Objective: The purpose of this article is to describe BPPV in COVID-19 patients by discussing the possible mechanisms underlying the onset of this vertigo. Methods: We studied eight patients (4 F, 4 M, aged between 44 and 69 years) with COVID-19 infections complaining of vertigo. Patients were evaluated at the end of infection with an accurate clinical history, and the investigation of spontaneous, positional and positioning nystagmus. Results: The vestibular findings showed benign paroxysmal positional vertigo (BPPV) in all the patients. Three patients had a mild phenotype of the COVID infection, whereas five subjects were hospitalized for the COVID infection and in three cases intensive care was required. Vestibular evaluation showed an involvement of posterior semicircular canals in five patients and horizontal in three. Three patients were treated with the Epley maneuver, two with Semont, one with Lempert and two with Gufoni maneuvers. Conclusions: We hypothesize that BPPV in COVID-19 infections can be relate to drugs, prolonged bed rest and to direct damage by viral infection on the peripheral vestibular system and in particular on the otolitic membrane due to the cytopathic effect of the virus and to the inflammatory response. Studies on large series of patients are needed to confirm our preliminary observation and to better evaluate the pathophysiological mechanisms underlying BPPV in these patients. View Full-Text
Keywords: COVID-19; vertigo; vestibular; BPPV COVID-19; vertigo; vestibular; BPPV
MDPI and ACS Style

Picciotti, P.M.; Passali, G.C.; Sergi, B.; De Corso, E. Benign Paroxysmal Positional Vertigo (BPPV) in COVID-19. Audiol. Res. 2021, 11, 418-422.

AMA Style

Picciotti PM, Passali GC, Sergi B, De Corso E. Benign Paroxysmal Positional Vertigo (BPPV) in COVID-19. Audiology Research. 2021; 11(3):418-422.

Chicago/Turabian Style

Picciotti, Pasqualina M., Giulio C. Passali, Bruno Sergi, and Eugenio De Corso. 2021. "Benign Paroxysmal Positional Vertigo (BPPV) in COVID-19" Audiology Research 11, no. 3: 418-422.

Find Other Styles

Article Access Map by Country/Region

Back to TopTop